New microRNAs for the diagnosis of cardiomyopathies

  • The present invention provides an in vitro method for obtaining data useful for diagnosing a cardiomyopathy, measuring the expression levels of two microRNAs in the blood plasma of patients.

    Given the absence of methods capable of assuring a degree of acceptable specificity and sensitivity for the diagnosis of myocarditis, particularly during an acute episode, the present invention solves this problem by providing a specific and sensitive assay for diagnosing myocarditis by using blood samples.

    Number
    EP15382596
    Priority date
    01/12/2015
    Aplicants
    CNIC
    Inventors
    Pilar Martín Fernández; Raquel Sánchez Díaz; Adela Matesanz Marín; Jesús Jiménez Borreguero; Francisco Sánchez Madrid